Joshua Disbrow
Chief Executive Officer chez AYTU BIOPHARMA, INC.
Fortune : 989 685 $ au 31/03/2024
Profil
Joshua R.
Disbrow is currently the Chief Executive Officer & Secretary at Innovus Pharmaceuticals, Inc., the Chairman & Chief Executive Officer at Aytu Biopharma, Inc., an Independent Director at Zynex, Inc., and a Director at Zynex Medical, Inc. Previously, he served as the President & Chief Executive Officer at Rosewind Corp., Luoxis Diagnostics, Inc., and Neos Therapeutics, Inc. He also held positions such as Marketing Director at LipoScience, Inc., Manager-Regional Sales at LivaNova USA, Inc., Vice President-Commercial Operations at Arbor Pharmaceuticals LLC, and Chief Operating Officer at Ampio Pharmaceuticals, Inc. Mr. Disbrow holds an MBA from Wake Forest University and an undergraduate degree from North Carolina State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZYNEX, INC.
0,19% | 19/03/2024 | 62 413 ( 0,19% ) | 772 049 $ | 31/03/2024 |
AYTU BIOPHARMA, INC.
1,29% | 11/08/2023 | 71 591 ( 1,29% ) | 217 637 $ | 31/03/2024 |
Postes actifs de Joshua Disbrow
| Sociétés | Poste | Début |
|---|---|---|
| AYTU BIOPHARMA, INC. | Chief Executive Officer | 16/04/2015 |
| ZYNEX, INC. | Director/Board Member | 06/03/2018 |
| INNOVUS PHARMACEUTICALS INC | Chief Executive Officer | - |
Zynex Medical, Inc.
 Zynex Medical, Inc. Medical SpecialtiesHealth Technology Zynex Medical, Inc. provides healthcare products and services. It develops products for cardiac monitoring for use in hospitals. The company was founded by Birgitte Sandgaard and Thomas Sandgaard in 1996 and is headquartered in Englewood, CO. | Director/Board Member | - |
Anciens postes connus de Joshua Disbrow
| Sociétés | Poste | Fin |
|---|---|---|
| AMPIO PHARMACEUTICALS, INC. | Chief Operating Officer | 16/04/2015 |
Arbor Pharmaceuticals LLC
 Arbor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Arbor Pharmaceuticals LLC develops pharmaceutical products, which focuses on cardiovascular, hospital and pediatric markets. It offers edarbyclor, cetylev, horizant, zenzedi, evekeo, sklice, and eryhromycin. The company was founded by Jarrett T. Disbrow and Edward J. Schutter and is headquartered in Atlanta, GA. | Chief Operating Officer | 01/10/2012 |
| CYBERONICS, INC. | Sales & Marketing | 01/04/2007 |
| LIPOSCIENCE INC | Sales & Marketing | 01/05/2005 |
| NEOS THERAPEUTICS, INC. | Chief Executive Officer | - |
Formation de Joshua Disbrow
| Wake Forest University | Masters Business Admin |
| North Carolina State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| ZYNEX, INC. | Health Technology |
| GSK PLC | Health Technology |
| AMPIO PHARMACEUTICALS, INC. | Health Technology |
| AYTU BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
LivaNova USA, Inc.
 LivaNova USA, Inc. Medical SpecialtiesHealth Technology LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX. | Health Technology |
LipoScience, Inc.
 LipoScience, Inc. Medical SpecialtiesHealth Technology LipoScience, Inc. develops and markets medical applications of Nuclear Magnetic Resonance. The firm provides advanced patient care for the patients who are suffering from cardiovascular, metabolic and other related diseases. The company was founded by James D. Otvos, Stephen K. Markham, and Richard A. Franco, Sr. and is headquartered in Raleigh, NC. | Health Technology |
Arbor Pharmaceuticals LLC
Arbor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Arbor Pharmaceuticals LLC develops pharmaceutical products, which focuses on cardiovascular, hospital and pediatric markets. It offers edarbyclor, cetylev, horizant, zenzedi, evekeo, sklice, and eryhromycin. The company was founded by Jarrett T. Disbrow and Edward J. Schutter and is headquartered in Atlanta, GA. | Health Technology |
Rosewind Corp.
 Rosewind Corp. Other Consumer ServicesConsumer Services Rosewind Corp. operates offshore sailing school. Its curriculum consists of a fast track experience for up to two student sailors who voyage for a week or more and topics include marine environment and safety at sea, life rafts and ditch bags, medical preparedness and fist aid, features of offshore capable vessels, rigging and deck gear and other. Rosewind was founded on August 9, 2002 and is headquartered in Loveland, CO. | Consumer Services |
Innovus Pharmaceuticals, Inc.
 Innovus Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Innovus Pharmaceuticals, Inc. engages in the commercialization, licensing, and development of non-prescription medicine, and consumer care products for health and vitality, and respiratory diseases. Its products focuses in six main categories, including sexual health, pain management, general muscle health, respiratory, sleep, and diabetic care. The company was founded on January 15, 1959 and is headquartered in Englewood, CO. | Health Technology |
| Luoxis Diagnostics, Inc. | Health Technology |
Zynex Medical, Inc.
Zynex Medical, Inc. Medical SpecialtiesHealth Technology Zynex Medical, Inc. provides healthcare products and services. It develops products for cardiac monitoring for use in hospitals. The company was founded by Birgitte Sandgaard and Thomas Sandgaard in 1996 and is headquartered in Englewood, CO. | Health Technology |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
